CNS Pharmaceuticals, Inc. (CNSP) Operating cash flow 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$13.8MFY2025 · since FY2018: -$716,385 → -$13.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.8M | +19.3% |
| FY2024 | -$17.1M | -21.0% |
| FY2023 | -$14.1M | -33.9% |
| FY2022 | -$10.6M | +22.0% |
| FY2021 | -$13.5M | -85.0% |
| FY2020 | -$7.3M | -105.9% |
| FY2019 | -$3.6M | -396.0% |
| FY2018 | -$716,385 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNSP financial trends
CNSP RevenueCNSP Net incomeCNSP Net marginCNSP Gross profitCNSP Gross marginCNSP Operating incomeCNSP Operating marginCNSP Free cash flowCNSP Capital expendituresCNSP Return on equityCNSP Stock buybacksCNSP Dividends paidCNSP Total assetsCNSP Total liabilitiesCNSP Shareholders’ equityCNSP overview →